Nobivac Ducat

Land: Storbritannien

Språk: engelska

Källa: VMD (Veterinary Medicines Directorate)

Aktiva substanser:

Feline calicivirus, Feline viral rhinotracheitis virus

Tillgänglig från:

MSD Animal Health UK Limited

ATC-kod:

QI06AD03

INN (International namn):

Feline calicivirus, Feline viral rhinotracheitis virus

Läkemedelsform:

Lyophilisate for suspension for injection

Receptbelagda typ:

POM-V - Prescription Only Medicine – Veterinarian

Terapeutisk grupp:

Cats

Terapiområde:

Live Viral Vaccine

Bemyndigande status:

Authorized

Tillstånd datum:

2004-10-18

Produktens egenskaper

Revised: March 2023
AN: 00679/2022
Page 1 of 5
SUMMARY OF PRODUCT CHARACTERISTICS
1.
NAME OF THE VETERINARY MEDICINAL PRODUCT
Nobivac Ducat lyophilisate and solvent for suspension for injection,
for cats
2.
QUALITATIVE AND QUANTITATIVE COMPOSITION
Each dose (1 ml) of reconstituted vaccine contains:
ACTIVE SUBSTANCES:
Live attenuated feline calicivirus, strain F9:

10
4.6
PFU
2
.
Live attenuated feline rhinotracheitis virus, strain G2620A:

10
4.8
TCID
50
1
;
1
TCID
50
:Tissue Culture Infectious Dose 50%
2
PFU: Plaque-Forming Units
EXCIPIENTS:
QUALITATIVE COMPOSITION OF EXCIPIENTS AND OTHER CONSTITUENTS_ _
Lyophilisate:
Disodium phosphate dihydrate
Hydrolysed gelatin
Sucrose
Solvent:
Disodium phosphate dihydrate
Potassium dihydrogen phosphate
Water for injections
Lyophilisate: off-white pellet.
Solvent: clear colourless solution.
3.
CLINICAL INFORMATION
3.1
TARGET SPECIES
Cats.
3.2
INDICATIONS FOR USE FOR EACH TARGET SPECIES
Active immunisation of cats to reduce the clinical signs caused by
infection with feline
rhinotracheitis virus (FVR) and feline calicivirus infections (FCV).
Onset of immunity: 4 weeks.
Duration of immunity: 1 year.
Revised: March 2023
AN: 00679/2022
Page 2 of 5
3.3
CONTRAINDICATIONS
See section 3.7.
3.4
SPECIAL WARNINGS
Vaccination at six weeks of age has been proven to be safe.
Vaccinate healthy animals only.
3.5
SPECIAL PRECAUTIONS FOR USE
Special precautions for safe use in the target species:
Care should be taken that aerosol is not formed when vaccinating the
cat as nasal or
oral exposure could result in clinical respiratory signs including
lethargy and malaise.
For the same reason, the cat should be prevented from licking the
injection site.
Special precautions to be taken by the person administering the
veterinary medicinal
product to animals:
In case of accidental self-injection, seek medical advice immediately
and show the
package leaflet or the label to the physician.
Special precautions for the protection of the environment:
Not applicable.
3.6
ADVERSE EVENTS
Cats:
Very commo